pI: 5.7871 |
Length (AA): 992 |
MW (Da): 113602 |
Paralog Number:
8
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_129304)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G01830 | histidine kinase 4 |
Arabidopsis thaliana | AT5G35750 | histidine kinase 2 |
Arabidopsis thaliana | AT1G27320 | histidine kinase 3 |
Candida albicans | CaO19.12648 | histidine kinase osmosensor |
Candida albicans | CaO19_5181 | hypothetical protein |
Candida albicans | CaO19.5181 | histidine kinase osmosensor |
Dictyostelium discoideum | DDB_G0277883 | HisK family protein kinase |
Escherichia coli | b2786 | hybrid sensory histidine kinase, in two-component regulatory system with UvrY |
Oryza sativa | 9271913 | Os01g0923700 |
Oryza sativa | 4348447 | Os10g0362300 |
Schmidtea mediterranea | mk4.071585.00 | |
Schmidtea mediterranea | mk4.029167.00 | |
Trichomonas vaginalis | TVAG_147200 | sensory transduction histidine kinase bacterial, putative |
Trichomonas vaginalis | TVAG_107010 | sensor histidine kinase, putative |
Trichomonas vaginalis | TVAG_000590 | two component sensor and regulator histidine kinase bacteria, putative |
Trichomonas vaginalis | TVAG_213160 | sensory transduction histidine kinase, putative |
Trichomonas vaginalis | TVAG_053990 | receptor histidine kinase, putative |
Trichomonas vaginalis | TVAG_304230 | sensor histidine kinase, putative |
Trichomonas vaginalis | TVAG_239940 | receptor histidine kinase, putative |
Trichomonas vaginalis | TVAG_005560 | sensory transduction histidine kinase bacterial, putative |
Trichomonas vaginalis | TVAG_013040 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
b2786 | Escherichia coli | non-essential | goodall |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Arabidopsis thaliana | histidine kinase 4 | Compounds | References |
Arabidopsis thaliana | histidine kinase 3 | Compounds | References |